Earflo Inc.

Earflo Inc. develops an innovative, non-invasive medical device for treating negative middle ear pressure (eustachian tube dysfunction) in children aged two and older. The device is designed to resemble a child's sippy cup and works by sensing swallowing and delivering gentle air pressure to the nasopharynx, helping to open the eustachian tube and allow trapped fluid to drain naturally. This approach addresses otitis media with effusion and chronic ear infections while avoiding surgical intervention. The company's product is intended to prevent hearing loss, reduce pain and behavioral/sleep disruption, and minimize developmental delays associated with untreated middle ear pressure disorders. Earflo was developed by biomedical engineers and ENT specialists and has received recognition as Best of Innovation in Digital Health at CES 2026. The device is FDA 510(k) pending and includes a companion mobile app to support treatment compliance and engagement. The product targets pediatric patients and their families seeking non-surgical management of common ear conditions. Currently not available for commercial purchase; the company is in the regulatory approval phase.